Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
About Renal Denervation
Renal denervation is a catheter-based minimally-invasive ablation procedure that helps reduce systolic blood pressure in individuals with drug-resistant hypertension. Systolic blood pressure is the first recorded reading. Diastolic blood pressure measures the pressure in the blood vessels when the heart rests between beats. The renal denervation catheter is introduced through the femoral artery in the upper thigh. The physician then makes several lesions using radiofrequency or ultrasound along the sympathetic nerves. These nerves connect the brain, heart, blood vessels, and kidneys, and play a major role in the management of hypertension.
Technavio’s analysts forecast the global renal denervation market to grow at a CAGR of 11.82% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global renal denervation market for 2016-2020. To calculate the market size, Technavio considers the revenue generated from the sales of renal denervation devices as the demand for these devices is high.
The market is divided into the following segments based on geography:
• Europe
• ROW
Technavio's report, Global Renal Denervation Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• Boston Scientific
• Medtronic
• ReCor Medical
• St. Jude Medical
Other prominent vendors
• Cardiosonic
• Cordis (a subsidiary of Johnson & Johnson)
• Kona Medical
• Sound Intervention
• Terumo
Market driver
• Widespread prevalence of hypertension
• For a full, detailed list, view our report
Market challenge
• Negative results of clinical studies
• For a full, detailed list, view our report
Market trend
• Funding for development of therapies
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Renal denervation is a catheter-based minimally-invasive ablation procedure that helps reduce systolic blood pressure in individuals with drug-resistant hypertension. Systolic blood pressure is the first recorded reading. Diastolic blood pressure measures the pressure in the blood vessels when the heart rests between beats. The renal denervation catheter is introduced through the femoral artery in the upper thigh. The physician then makes several lesions using radiofrequency or ultrasound along the sympathetic nerves. These nerves connect the brain, heart, blood vessels, and kidneys, and play a major role in the management of hypertension.
Technavio’s analysts forecast the global renal denervation market to grow at a CAGR of 11.82% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global renal denervation market for 2016-2020. To calculate the market size, Technavio considers the revenue generated from the sales of renal denervation devices as the demand for these devices is high.
The market is divided into the following segments based on geography:
• Europe
• ROW
Technavio's report, Global Renal Denervation Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• Boston Scientific
• Medtronic
• ReCor Medical
• St. Jude Medical
Other prominent vendors
• Cardiosonic
• Cordis (a subsidiary of Johnson & Johnson)
• Kona Medical
• Sound Intervention
• Terumo
Market driver
• Widespread prevalence of hypertension
• For a full, detailed list, view our report
Market challenge
• Negative results of clinical studies
• For a full, detailed list, view our report
Market trend
• Funding for development of therapies
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
